Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Gabapentin for Carpal Tunnel Syndrome
NCT01632215Phase 3
Key facts
- Status
- Completed
- Start
- Mar 2010
- Primary completion
- Aug 2011
- Sponsor
- Federal University of São Paulo
- Modality
- Small Molecules
- Drugs
- gabapentin
- Conditions
- carpal tunnel syndrome (CTS)
01
Overview
Phase 3, randomised, double-blind trial in carpal tunnel syndrome (CTS) comparing Gabapentin with Placebo (2 arms). Primary endpoint: Pain Intensity at 6 months. Started Mar 2010; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Gabapentin
Gabapentin 600 mg
Placebo
Sugar pill
03
Who it enrols
Patients with carpal tunnel syndrome. Excludes patients with disorientation, psychiatric disease, myocardial ischemia, hypertension, arrhythmia, another pain syndrome, drug users, and pregnant women.
04
Endpoints
Primary
Pain Intensity
Secondary
Chronic Pain
Beyond the preview
Go deeper on NCT01632215.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01632215.